The research is being led from CNS Healthcare’s location in the GAI building downtown, on E. South Street (updated to reflect correct location), and its main goal is the prevention of COVID-19 in those who have and have not already been infected prior to immunization. Another objective of the trials is to prevent severe COVID-19 in those two groups.
The randomized, observer-blinded study is seeking non-pregnant adults between the ages of 18 and 85. You can find out if you fit their criteria to participate at covidvaccinestudy.com.
“Researchers are in a race to find ways to prevent and end the spread of COVID-19,” says the enrollment form for volunteers to become candidates to try out possible vaccines and medications to treat the effects of the virus. CNS says finding interested volunteers “is crucial in speeding up enrollment in the trials that will provide answers and solutions.” “Researchers are in a race to find ways to prevent and end the spread of COVID-19.”
Specifically, the trial is phases 2 and 3 of a global study sponsored by Pfizer Inc. and BioNTech SE, of an investigational vaccine called BNT162b2 against the virus causing the current global pandemic, SARS-CoV-2.
Half the study participants are given placebos, which contain nonactive ingredients, against which they will test the effectiveness of the drug on the other half.
CNS says information submitted is strictly confidential and will not be used for any other purpose.
People interested in participating can learn more at the CNS Healthcare website, www.covid19research.us.

Please follow CDC guidelines and Orange County advisories to stay safe, and please support this free publication. Our small but mighty team is working tirelessly to bring you news on how coronavirus is affecting Central Florida. Please consider making a one-time or monthly donation. Every little bit helps.
This article appears in Jul 22-28, 2020.

